Our Mission 

Our mission is to enable every person in the world to fully enjoy their vision potential.

Therefore, we develop and market innovative ophthalmic implants that mend and replace damaged tissue while mimicking its function.

 

In order to fulfill this vision we promote the following core values:

InnovationOut-of-the-box thinking is our way of life. We believe in revolutionary thinking across our operations and do not adopt existing practices, systems, processes, and solutions without truly challenging them. We believe in a multi-disciplinary approach to problem solving and encourage diversified thinking.

 

TeamOur employees are our most valuable resource. We promote learning and personal development of our staff while making sure they all feel at home, included and united. The team will work inclusively, in cooperation, leveraging individual talent and mutual inspiration to achieve excellence.

 

EqualityWe believe that everyone has the right to see hence will leverage our business development, distribution power, clinical operations and training activities to introduce and offer our solutions in developing and impoverished countries.

 

Customer FocusOur primary customers are patients and physicians who use our products. We prioritize physician experience and ease of use.  We value aesthetics and its importance to our customer base (physicians and patients) and aim to develop solutions that respect this.

QualityWe constantly invest in improving the quality of our products and processes with an aim to exceed customer expectations.

 

Management Team

Experienced team with a multi-disciplinary background 

Image-empty-state.png

Gilad Litvin, MD

Co-Founder, Chairman, Chief Medical Officer

Image-empty-state.png

Gil Lotan, Adv.

VP Business Development

Image-empty-state.png

Almog Aley-Raz

Co-Founder, Chief Executive Officer, VP of Research and Development

Image-empty-state.png

Sapir Buchris, Adv.

Director of Operations & Corporate Development

Image-empty-state.png

Gerry Tal

VP Quality, Regulatory and Clinical Affairs

 
%D7%A8%D7%A7%D7%A2-01_edited.jpg

Scientific Advisory Board

CorNeat Vision’s Advisory Board consists of the world’s top ophthalmologists and ophthalmic innovators in cornea, glaucoma, and anterior chamber devices and surgery. Together, they have published over 650 peer reviewed papers. 

Our Scientific Advisory Board consists of key opinion leaders from Israel, Canada, US, France, and China, who are planned to take an active role in our clinical trials and subsequent regulatory submissions.
 

Ehud Assia, MD

Ehud Assia, MD

Israel

Zuguo Liu, MD, PhD

Zuguo Liu, MD, PhD

China

R. Doyle Stulting, MD, PhD

R. Doyle Stulting, MD, PhD

United States

David Rootman, MD, FRCSC

David Rootman, MD, FRCSC

Canada

Ike Ahmed, MD, FRCSC

Ike Ahmed, MD, FRCSC

Canada

Eric Gabison, MD, PhD

Eric Gabison, MD, PhD

France

Edward J. Holland, MD

Edward J. Holland, MD

United States

 

Scientific Collaboration

Toam Katz, MD

Toam Katz, MD

Germany

%D7%A8%D7%A7%D7%A2-01_edited.jpg

Awards & Accreditations

EU Horizon 2020 Seal of Excellence Award 2020

EU Horizon 2020 Seal of Excellence Award 2020

Xi’an International Startup Competition, Second Prize Winner

Xi’an International Startup Competition, Second Prize Winner

CorNeat Vision Wins the Finals of China (Shenzhen) Innovation & Entrepreneurship Int’l Competition

CorNeat Vision Wins the Finals of China (Shenzhen) Innovation & Entrepreneurship Int’l Competition

EU Horizon 2020 Seal of Excellence 2018

EU Horizon 2020 Seal of Excellence 2018

MIXiii BIOMED Startup of the Year Award

MIXiii BIOMED Startup of the Year Award

EU Horizon 2020 Seal of Excellence 2017

EU Horizon 2020 Seal of Excellence 2017

 
 

Major Milestones 

 
%D7%A8%D7%A7%D7%A2-01_edited.jpg

info@corneat.com

Visit us at
4 HaSheizaf St.

Ra'anana, Israel

Join Our Mailing List